TF and carcinoma: Simple mucin-type O-glycosylated TACAs, such as the Tn antigen (CD175), the TF antigen (or T antigen, CD176), and the sialyl-Tn antigen (STn, CD175s), are attractive targets for anticancer therapies because they are detected in most carcinomas and are usually absent in healthy tissues [144].